GlyR$\alpha3$: An Essential Target for Spinal$PGE_2-Mediated$Inflammatory Pain Sensitization

Prostaglandin E2(PGE2) is a crucial mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype ($GlyR \alpha3$) by$PGE_2-induced$receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR$\alpha3$is dist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2004-05, Vol.304 (5672), p.884-887
Hauptverfasser: Harvey, Robert J., Depner, Ulrike B., Wässle, Heinz, Ahmadi, Seifollah, Heindl, Cornelia, Reinold, Heiko, Smart, Trevor G., Harvey, Kirsten, Schütz, Burkhard, Abo-Salem, Osama M., Zimmer, Andreas, Poisbeau, Pierrick, Welzl, Hans, Wolfer, David P., Betz, Heinrich, Zeilhofer, Hanns Ulrich, Müller, Ulrike
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Prostaglandin E2(PGE2) is a crucial mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype ($GlyR \alpha3$) by$PGE_2-induced$receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR$\alpha3$is distinctly expressed in superficial layers of the spinal cord dorsal horn. Mice deficient in GlyR$\alpha3$not only lack the inhibition of glycinergic neurotransmission by PGE2seen in wildtype mice but also show a reduction in pain sensitization induced by spinal PGE2injection or peripheral inflammation. Thus, GlyR$\alpha3$may provide a previously unrecognized molecular target in pain therapy.
ISSN:0036-8075
1095-9203